Search research articles
Contact Us
Filters
Showing results (381-390 of 423) with videos related to
Page
of 43
Sort By:
The Lancet. Neurology
|
December 6, 2011
Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data
Sarah J Tabrizi, Ralf Reilmann, Raymund A C Roos, et al.
The Lancet. Neurology
|
December 7, 2010
Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis
Sarah J Tabrizi, Rachael I Scahill, Alexandra Durr, et al.
JCI Insight
|
April 20, 2017
Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington's disease
Peter McColgan, Kiran K Seunarine, Sarah Gregory, et al.
Brain : a Journal of Neurology
|
March 24, 2017
Operationalizing compensation over time in neurodegenerative disease
Sarah Gregory, Jeffrey D Long, Stefan Klöppel, et al.
Plos One
|
January 14, 2025
Beekeepers' perceptions toward a new omics tool for monitoring bee health in Europe
Elena Cini, Simon G Potts, Deepa Senapathi, et al.
Human Brain Mapping
|
January 26, 2011
Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease
Eve M Dumas, Simon J A van den Bogaard, Margot E Ruber, et al.
Nature Communications
|
February 16, 2026
Mithramycin alters EWS::FLI1 DNA binding and RNA polymerase II processivity to inhibit nascent transcription
Rebecca Kaufman, Guillermo Flores, Elissa A Boguslawski, et al.
Plos One
|
January 15, 2014
Agricultural policies exacerbate honeybee pollination service supply-demand mismatches across Europe
Tom D Breeze, Bernard E Vaissière, Riccardo Bommarco, et al.
The Lancet. Neurology
|
January 27, 2024
Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study
Ralf Reilmann, Karen E Anderson, Andrew Feigin, et al.
Nature Reviews. Neurology
|
March 12, 2014
Huntington disease: natural history, biomarkers and prospects for therapeutics
Christopher A Ross, Elizabeth H Aylward, Edward J Wild, et al.
Page
of 43
Search research articles
Search
Showing results (381-390 of 423) with videos related to
Sort By:
Page
of 43
The Lancet. Neurology
|
December 6, 2011
Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data
Sarah J Tabrizi, Ralf Reilmann, Raymund A C Roos, et al.
The Lancet. Neurology
|
December 7, 2010
Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis
Sarah J Tabrizi, Rachael I Scahill, Alexandra Durr, et al.
JCI Insight
|
April 20, 2017
Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington's disease
Peter McColgan, Kiran K Seunarine, Sarah Gregory, et al.
Brain : a Journal of Neurology
|
March 24, 2017
Operationalizing compensation over time in neurodegenerative disease
Sarah Gregory, Jeffrey D Long, Stefan Klöppel, et al.
Plos One
|
January 14, 2025
Beekeepers' perceptions toward a new omics tool for monitoring bee health in Europe
Elena Cini, Simon G Potts, Deepa Senapathi, et al.
Human Brain Mapping
|
January 26, 2011
Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease
Eve M Dumas, Simon J A van den Bogaard, Margot E Ruber, et al.
Nature Communications
|
February 16, 2026
Mithramycin alters EWS::FLI1 DNA binding and RNA polymerase II processivity to inhibit nascent transcription
Rebecca Kaufman, Guillermo Flores, Elissa A Boguslawski, et al.
Plos One
|
January 15, 2014
Agricultural policies exacerbate honeybee pollination service supply-demand mismatches across Europe
Tom D Breeze, Bernard E Vaissière, Riccardo Bommarco, et al.
The Lancet. Neurology
|
January 27, 2024
Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study
Ralf Reilmann, Karen E Anderson, Andrew Feigin, et al.
Nature Reviews. Neurology
|
March 12, 2014
Huntington disease: natural history, biomarkers and prospects for therapeutics
Christopher A Ross, Elizabeth H Aylward, Edward J Wild, et al.
Page
of 43